Search Trials
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
Status:
Not yet recruiting
Last Changed:
Nov 3, 2021
First Changed:
Nov 3, 2021
Disease(s):
Non-Alcoholic Fatty Liver Disease
Intervention(s):
serum Adiponectin
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Status:
Completed
Last Changed:
Jan 18, 2018
First Changed:
Sep 27, 2007
Disease(s):
Impaired Glucose Tolerance
Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Status:
Unknown status
Last Changed:
Dec 29, 2011
First Changed:
Dec 29, 2011
Disease(s):
Insulin-requiring Type 2 Diabetes Mellitus
Intervention(s):
nph insulinhuman insulinInsulin GlargineInsulin glulisine
Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
Status:
Completed
Last Changed:
Feb 20, 2013
First Changed:
Oct 17, 2007
Disease(s):
Insulin Resistance
Intervention(s):
Roux-en-Y Gastric Bypass plus total omentectomyRoux-en-Y Gastric Bypass
Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study
Status:
Terminated
Last Changed:
Jul 23, 2010
First Changed:
Dec 3, 2007
Disease(s):
Diabetes Mellitus, Type 2
Intervention(s):
Duodenal exclusion plus omentectomyDuodenal exclusion without omentectomy

Connect. Empower. Inspire.